Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nasopharyngeal Cancer Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00524017
What this trial is testing

Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract

Who this might be right for
Head and Neck CancerPrecancerous Condition
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Large-scale testing (Phase 3)UnknownNCT01536223
What this trial is testing

Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma

Who this might be right for
ChemoradiationNasopharyngeal Carcinoma
Zhejiang Cancer Hospital 400
Large-scale testing (Phase 3)Looking for participantsNCT06277050
What this trial is testing

Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaHigh-Risk CancerMaintenance Therapy
Jiangxi Provincial Cancer Hospital 264
Large-scale testing (Phase 3)Study completedNCT01528618
What this trial is testing

Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 362
Testing effectiveness (Phase 2)Looking for participantsNCT07332247
What this trial is testing

PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC

Who this might be right for
Nasopharangeal CancerRecurrent Nasopharynx Carcinoma
Sun Yat-sen University 94
Testing effectiveness (Phase 2)Ended earlyNCT01192815
What this trial is testing

Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck

Who this might be right for
Stage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the LarynxStage III Squamous Cell Carcinoma of the Lip and Oral Cavity+9 more
Case Comprehensive Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT04736810
What this trial is testing

Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Akeso 28
Large-scale testing (Phase 3)Study completedNCT01156142
What this trial is testing

Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Who this might be right for
Head and Neck CancerMucositisOral Complications of Radiation Therapy+1 more
Alliance for Clinical Trials in Oncology 155
Testing effectiveness (Phase 2)Study completedNCT03848286
What this trial is testing

KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaRecurrent or Metastatic
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 153
Large-scale testing (Phase 3)Study completedNCT00017511
What this trial is testing

Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerOral ComplicationsRadiation Toxicity
Daiichi Sankyo
Testing effectiveness (Phase 2)UnknownNCT03890185
What this trial is testing

Docetaxal & Cisplatin vs LDFRT + Docetaxal & Cisplatin in Locally Advanced NPC

Who this might be right for
Nasopharyngeal Cancer
King Faisal Specialist Hospital & Research Center 108
Testing effectiveness (Phase 2)Study completedNCT00101335
What this trial is testing

Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

Who this might be right for
Head and Neck CancerPrecancerous Condition
Fox Chase Cancer Center
Early research (Phase 1)Study completedNCT01256853
What this trial is testing

Modified Vaccinia Ankara (MVA) Vaccine Study

Who this might be right for
Nasopharyngeal NeoplasmsEpstein-Barr Virus Infections
Chinese University of Hong Kong 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05484375
What this trial is testing

Capecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma After First-line Treatment

Who this might be right for
Metastatic Nasopharyngeal Carcinoma
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 40
Large-scale testing (Phase 3)UnknownNCT03321539
What this trial is testing

Phase Ⅲ Trial of Adjuvant Chemotherapy in Patients With N2-3 Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 216
Large-scale testing (Phase 3)Not Yet RecruitingNCT06775756
What this trial is testing

Reducing Dose and Irradiated Volume in Cervical Prophylactic Irradiation for Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Carcinoma
Fujian Cancer Hospital 474
Testing effectiveness (Phase 2)UnknownNCT05162872
What this trial is testing

Niraparib And Sintilimab In Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 99
Large-scale testing (Phase 3)Looking for participantsNCT05877872
What this trial is testing

Reduced-target Resection After Induction Chemotherapy in Resectable Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaDe-escaltion Therapy
Sun Yat-sen University 424
Testing effectiveness (Phase 2)Study completedNCT00058006
What this trial is testing

Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer

Who this might be right for
Head and Neck CancerLung Cancer
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00006033
What this trial is testing

Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
H. Lee Moffitt Cancer Center and Research Institute
Next Page